Estadístiques de Semaglutide improves liver steatosis and de novo lipogenesis markers in obese and type-2-diabetic mice with metabolic-dysfunction-associated steatotic liver disease

Visites totals

views
Semaglutide improves liver steatosis and de novo lipogenesis markers in obese and type-2-diabetic mice with metabolic-dysfunction-associated steatotic liver disease 3

Visites totals per mes

views
January 2025 0
February 2025 0
March 2025 0
April 2025 0
May 2025 0
June 2025 3
July 2025 0

Visites al fitxer

views
Soto_ijm_sema.pdf 17